UnknownNot applicableNCT04849754

Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy

Studying Amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Principal Investigator
Fredric MOUQUET
Hôpital Privé Le Bois
Intervention
bone scintigraphy(diagnostic_test)
Enrollment
30 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04849754 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials